| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.18 | 1-year : | 2.6 |
| Resists | First : | 1.87 | Second : | 2.22 |
| Pivot price | 1.71 |
|||
| Supports | First : | 1.29 | Second : | 1.08 |
| MAs | MA(5) : | 1.79 |
MA(20) : | 1.65 |
| MA(100) : | 1.51 |
MA(250) : | 1.4 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 36.7 |
D(3) : | 48.8 |
| RSI | RSI(14): 47.9 |
|||
| 52-week | High : | 2.22 | Low : | 0.93 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ NNVC ] has closed above bottom band by 34.4%. Bollinger Bands are 172.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.03 - 2.05 | 2.05 - 2.06 |
| Low: | 1.62 - 1.64 | 1.64 - 1.65 |
| Close: | 1.66 - 1.68 | 1.68 - 1.7 |
Tue, 11 Nov 2025
Is NNVC stock undervalued vs historical averages - Weekly Trend Report & AI Powered Market Entry Strategies - newser.com
Tue, 11 Nov 2025
What dividend safety rating applies to NNVC stock - Earnings Overview Summary & Reliable Price Breakout Alerts - newser.com
Tue, 11 Nov 2025
NanoViricides (NYSE American: NNVC) prices $6M offering; exercisable in 6 months - Stock Titan
Tue, 11 Nov 2025
NanoViricides raises $6M in direct offering with institutional investor - Proactive financial news
Mon, 10 Nov 2025
NanoViricides (NYSE American: NNVC) cleared in DRC to begin NV-387 Phase 2 Mpox trial - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 12 (M) |
| Shares Float | 11 (M) |
| Held by Insiders | 4.5 (%) |
| Held by Institutions | 11.3 (%) |
| Shares Short | 473 (K) |
| Shares Short P.Month | 348 (K) |
| EPS | -0.82 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.89 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -40.8 % |
| Return on Equity (ttm) | -65.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.77 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -6 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -1.95 |
| PEG Ratio | 0 |
| Price to Book value | 1.77 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.98 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|